Literature DB >> 24140862

Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia.

Justine M Abais1, Min Xia1, Guangbi Li1, Todd W B Gehr2, Krishna M Boini1, Pin-Lan Li3.   

Abstract

Hyperhomocysteinemia (hHcys) is an important pathogenic factor contributing to the progression of end-stage renal disease. Recent studies have demonstrated the implication of nicotinamide adenine dinucleotide phosphate oxidase-mediated NLRP3 inflammasome activation in the development of podocyte injury and glomerular sclerosis during hHcys. However, it remains unknown which reactive oxygen species (ROS) are responsible for this activation of NLRP3 inflammasomes and how such action of ROS is controlled. This study tested the contribution of common endogenous ROS including superoxide (O2(-)), hydrogen peroxide (H2O2), peroxynitrite (ONOO(-)), and hydroxyl radical (OH) to the activation of NLRP3 inflammasomes in mouse podocytes and glomeruli. In vitro, confocal microscopy and size-exclusion chromatography demonstrated that dismutation of O2(-) by 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (Tempol) and decomposition of H2O2 by catalase prevented Hcys-induced aggregation of NLRP3 inflammasome proteins and inhibited Hcys-induced caspase-1 activation and IL-1β production in mouse podocytes. However, scavenging of ONOO(-) or OH had no significant effect on either Hcys-induced NLRP3 inflammasome formation or activation. In vivo, scavenging of O2(-) by Tempol and removal of H2O2 by catalase substantially inhibited NLRP3 inflammasome formation and activation in glomeruli of hHcys mice as shown by reduced colocalization of NLRP3 with ASC or caspase-1 and inhibition of caspase-1 activation and IL-1β production. Furthermore, Tempol and catalase significantly attenuated hHcys-induced glomerular injury. In conclusion, endogenously produced O2(-) and H2O2 primarily contribute to NLRP3 inflammasome formation and activation in mouse glomeruli resulting in glomerular injury or consequent sclerosis during hHcys.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Free radicals; Glomerular sclerosis; Homocysteine; NLRP3 inflammasome; Redox signaling

Mesh:

Substances:

Year:  2013        PMID: 24140862      PMCID: PMC3945111          DOI: 10.1016/j.freeradbiomed.2013.10.009

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  69 in total

1.  Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene.

Authors:  Chun Zhang; Jun-Jun Hu; Min Xia; Krishna M Boini; Christopher A Brimson; Laura A Laperle; Pin-Lan Li
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

Review 2.  Paraoxonase 1 and homocysteine metabolism.

Authors:  Joanna Perła-Kaján; Hieronim Jakubowski
Journal:  Amino Acids       Date:  2012-05-29       Impact factor: 3.520

Review 3.  Homocysteine imbalance: a pathological metabolic marker.

Authors:  Kevin L Schalinske; Anne L Smazal
Journal:  Adv Nutr       Date:  2012-11-01       Impact factor: 8.701

4.  Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor-mediated vasorelaxation in transgenic cystathionine beta synthase-deficient mice.

Authors:  Zhongjian Cheng; Xiaohua Jiang; Warren D Kruger; Domenico Praticò; Sapna Gupta; Karthik Mallilankaraman; Muniswamy Madesh; Andrew I Schafer; William Durante; Xiaofeng Yang; Hong Wang
Journal:  Blood       Date:  2011-06-08       Impact factor: 22.113

5.  Role of H(2)O(2) in hypertension, renin-angiotensin system activation and renal medullary disfunction caused by angiotensin II.

Authors:  T Sousa; S Oliveira; J Afonso; M Morato; D Patinha; S Fraga; F Carvalho; A Albino-Teixeira
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

6.  Exercise prevents hyperhomocysteinemia in a dietary folate-restricted mouse model.

Authors:  Joshua C Neuman; Kelsey A Albright; Kevin L Schalinske
Journal:  Nutr Res       Date:  2013-05-18       Impact factor: 3.315

Review 7.  NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

Authors:  Jurg Tschopp; Kate Schroder
Journal:  Nat Rev Immunol       Date:  2010-02-19       Impact factor: 53.106

8.  Inflammasomes are differentially expressed in cardiovascular and other tissues.

Authors:  Y Yin; Y Yan; X Jiang; J Mai; N C Chen; H Wang; X-F Yang
Journal:  Int J Immunopathol Pharmacol       Date:  2009 Apr-Jun       Impact factor: 3.219

9.  Ricin Toxin Activates the NALP3 Inflammasome.

Authors:  Meghan Lindauer; John Wong; Bruce Magun
Journal:  Toxins (Basel)       Date:  2010-06-01       Impact factor: 4.546

10.  Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis.

Authors:  Krishna M Boini; Min Xia; Jing Xiong; Caixia Li; Lori P Payne; Pin-Lan Li
Journal:  J Cell Mol Med       Date:  2012-08       Impact factor: 5.310

View more
  39 in total

Review 1.  The emerging role of the inflammasome in kidney diseases.

Authors:  Anthony Chang; Kichul Ko; Marcus R Clark
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-05       Impact factor: 2.894

2.  NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.

Authors:  Guangbi Li; Zhida Chen; Owais M Bhat; Qinghua Zhang; Justine M Abais-Battad; Sabena M Conley; Joseph K Ritter; Pin-Lan Li
Journal:  J Lipid Res       Date:  2017-04-12       Impact factor: 5.922

3.  Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia.

Authors:  Sabena M Conley; Justine M Abais-Battad; Xinxu Yuan; Qinghua Zhang; Krishna M Boini; Pin-Lan Li
Journal:  Free Radic Biol Med       Date:  2017-02-11       Impact factor: 7.376

4.  Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.

Authors:  Tsuyoshi Majima; Pradeep Tyagi; Koji Dogishi; Mahendra Kashyap; Yasuhito Funahashi; Momokazu Gotoh; Michael B Chancellor; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2017-04-18       Impact factor: 5.695

Review 5.  Energy metabolism and inflammation in brain aging and Alzheimer's disease.

Authors:  Fei Yin; Harsh Sancheti; Ishan Patil; Enrique Cadenas
Journal:  Free Radic Biol Med       Date:  2016-05-03       Impact factor: 7.376

Review 6.  Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?

Authors:  Justine M Abais; Min Xia; Yang Zhang; Krishna M Boini; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2015-01-19       Impact factor: 8.401

Review 7.  Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit.

Authors:  Islam N Mohamed; Tauheed Ishrat; Susan C Fagan; Azza B El-Remessy
Journal:  Antioxid Redox Signal       Date:  2014-11-11       Impact factor: 8.401

8.  Inhibition of hyperhomocysteinemia-induced inflammasome activation and glomerular sclerosis by NLRP3 gene deletion.

Authors:  Min Xia; Sabena M Conley; Guangbi Li; Pin-Lan Li; Krishna M Boini
Journal:  Cell Physiol Biochem       Date:  2014-08-20

9.  Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.

Authors:  Guangbi Li; Min Xia; Justine M Abais; Krishna Boini; Pin-Lan Li; Joseph K Ritter
Journal:  J Pharmacol Exp Ther       Date:  2016-05-11       Impact factor: 4.030

10.  Podocytopathy and Nephrotic Syndrome in Mice with Podocyte-Specific Deletion of the Asah1 Gene: Role of Ceramide Accumulation in Glomeruli.

Authors:  Guangbi Li; Jason Kidd; Cristin Kaspar; Sara Dempsey; Owais M Bhat; Sarah Camus; Joseph K Ritter; Todd W B Gehr; Erich Gulbins; Pin-Lan Li
Journal:  Am J Pathol       Date:  2020-03-16       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.